Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW 350 billion on February 3, 2023. The acquisition is subject to regulatory approval. Lazard & Co., Limited acted as financial advisor to Croda International Plc (LSE:CRDA).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,720 KRW | +1.70% | +0.18% | +26.19% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.19% | 894M | |
+17.34% | 111B | |
-1.65% | 30.11B | |
+9.23% | 22.24B | |
-10.15% | 19.41B | |
+18.56% | 16.81B | |
-9.69% | 16.61B | |
+5.65% | 12.6B | |
+1.09% | 11.1B | |
+14.89% | 8.65B |
- Stock Market
- Equities
- A336370 Stock
- News Solus Advanced Materials Co., Ltd.
- Croda International Plc agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. for KRW350 billion.